Atlas Trials

A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register

Clinical trial NCT05413044 · COMPLETED

Trial details

NCT number
NCT05413044
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid ArthritisPsoriatic Arthritis
Start date
2019-07-01
Primary completion
2025-08-22
Enrollment
140706

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.